aTYR PHARMA INC
ATYR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001339970
No open-market purchases or sales by aTYR PHARMA INC insiders were filed in the last 90 days; 89 institutions reported holding it in 13F filings for Q2 2026, worth $23.2M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding aTYR PHARMA INC changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 47 | 1 | 56 | +10 |
| Shares | 48.1M | 1.39M | 47.9M | +1.14M (+2.4%) |
| Value | $75.1M | $2.17M | $84.3M | +$11.3M (+15.6%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (15)
Institutions that held aTYR PHARMA INC at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 1,396,562 | $2.46M | 0.00% |
| Susquehanna International Group, LLP | 133,229 | $234.5K | 0.00% |
| Citigroup Inc | 132,983 | $234.1K | 0.00% |
| Knott David M Jr | 107,174 | $189.0K | 0.08% |
| Jefferies Financial Group Inc. | 55,600 | $97.9K | 0.00% |
| Occudo Quantitative Strategies LP | 20,826 | $36.7K | 0.01% |
| XTX Topco Ltd | 17,262 | $30.4K | 0.00% |
| StoneX Group Inc. | 15,709 | $27.6K | 0.00% |
| Engineers Gate Manager LP | 15,646 | $27.5K | 0.00% |
| Marshall Wace, LLP | 14,031 | $24.7K | 0.00% |
| Squarepoint Ops LLC | 13,381 | $23.6K | 0.00% |
| Two Sigma Securities, LLC | 12,992 | $22.9K | 0.00% |
| Ground Swell Capital, LLC | 12,728 | $22.4K | 0.03% |
| Continuum Advisory, LLC | 210 | $670 | 0.00% |
| National Bank of Canada | 358 | $630 | 0.00% |
Sold out (5)
Institutions that held aTYR PHARMA INC at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Superstring Capital Management LP | 313,028 | $488.3K |
| Sanctuary Advisors, LLC | 29,207 | $45.9K |
| Cubist Systematic Strategies, LLC | 16,485 | $25.7K |
| Verition Fund Management LLC | 12,675 | $19.8K |
| Cypress Capital, LLC | 200 | $312 |
Not filed for Q3 2024 yet (1)
Institutions that held aTYR PHARMA INC at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 1,392,074 | $2.17M |